Cytokinetics | CYTK - Market Capitalization

Stock Price
62.97
Daily Change
-1.76 -2.72%
Monthly
2.79%
Yearly
24.92%
Q1 Forecast
61.24

Cytokinetics reported $7.64B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.6B 10M Sep/2025
Amgen USD 184.41B 32.48B Feb/2026
Bayer EUR 27.23B 2.14B Sep/2025
Biogen USD 20.54B 2.13B Sep/2025
Bristol-Myers Squibb USD 91.8B 2.4B Sep/2025
Cytokinetics USD 6.58B 2.63B Sep/2025
Eisai JPY 1.45T 280.95B Sep/2025
Eli Lilly USD 1.02T 300.22B Feb/2026
Exelixis USD 10.79B 1.79B Sep/2025
Geron USD 874M 24M Sep/2025
Halozyme Therapeutics USD 8.58B 2.17B Sep/2025
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
Ligand Pharmaceuticals USD 3.42B 1.23B Sep/2025
Merck USD 293.38B 83.74B Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Pfizer USD 147.57B 12.48B Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025